Conversations and Reactions around Severe Hypoglycemia (CRASH): US Results from a Global Survey of People with T1DM or Insulin-Treated T2DM and Caregivers

被引：2

作者：

Snoek, Frank J.

Jiletcovici, Alina

Bushnell, Donald M., III

Child, Christopher J.

Bajpai, Sanjay K.

Spaepen, Erik

Thomas, Josh

Balantac, Zaneta

Peyrot, Mark

Mitchell, Beth

机构：

来源：

DIABETES | 2019年 / 68卷

关键词：

D O I：

10.2337/db19-285-OR

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

285-OR

引用

页数：3

共 50 条

[11] Insulin Dosing Formulas for Multiple Daily Injection-Treated T1DM and Pump-Treated T2DM Are the Same as Pump-Treated T1DM Subjects
King, Allen B.
DIABETES, 2014, 63 : A235 - A235
[12] Conversations and Reactions Around Severe Hypoglycaemia (CRASH): survey responses of people aged 65+with type 1 diabetes and insulin-treated type 2 diabetes and caregivers
Snoek, F.
Spaepen, E.
Bushnell, D. M.
Child, C. J.
Balantac, Z.
Mitchell, B. D.
Peyrot, M.
DIABETOLOGIA, 2020, 63 (SUPPL 1) : S360 - S361
[13] Insulin Degludec Results in Consistently Lower Rates of Nocturnal Hypoglycemia Despite Lower FPG Levels Compared to Insulin Glargine in Seven Trials With T1DM or T2DM
Russell-Jones, David
Del Prato, Stefano
Gall, Mari-Anne
Lassota, Nathan
Diamant, Michaela
DIABETES, 2012, 61 : A603 - A603
[14] Impact of Sitagliptin on Hypoglycemia in Elderly Subjects with T2DM Treated with Insulin
Shankar, R. Ravi
Long, Jianmin
Xu, Lei
O'Neill, Edward A.
Engel, Samuel S.
DIABETES, 2017, 66 : A585 - A586
[15] Local Tolerability of Insulin Degludec is Comparable to Insulin Glargine: A Meta-Analysis of T1DM and T2DM
Meneghini, Luigi F.
Schumm-Draeger, Petra-Maria
Harris, Stewart
Gall, Mari-Anne
Lassota, Nathan
Christiansen, Jens S.
DIABETES, 2012, 61 : A230 - A230
[16] Distinct Exhaled Gas Profiles in Obese, T1DM, and T2DM during Glucose and Insulin Fluctuations
Oliver, Stacy R.
Carlson, Matt K.
Cheung, Joanne
Ly, Alexandra R.
Flores, Rebecca L.
Blake, Donald R.
Galassetti, Pietro R.
DIABETES, 2011, 60 : A509 - A510
[17] Effect of Meal Replacements On Glycemic Control in Insulin-Treated Patients with T2DM
Beale, Elizabeth
Serafin-Dokhan, Sara
Lee, Wei-An
Peters, Anne
DIABETES, 2010, 59 : A702 - A702
[18] Evaluation of Immunogenicity of LY2963016 Insulin Glargine Compared with Lantus® Insulin Glargine in Patients with T1DM or T2DM
Deeg, Mark
Ilag, Liza
Huster, William J.
Pollom, Robyn K.
Zielonka, Jason
Prince, Melvin J.
Konrad, Robert J.
DIABETES, 2014, 63 : A19 - A19
[19] Novel Imperial Parameters of Insulin Resistance and Insulin Secretion Function Damage Assessment for Differential Diagnosis of T1DM and LADA from T2DM
Cao, Xiao
Cui, Shi Wei
Gu, Yun Juan
Zhu, Xiao Hui
DIABETES, 2017, 66 : A654 - A654
[20] Telemedicine and mHealth System for Complex Management in T1DM and T2DM Patients: Results of 6 Months Study
Lehocki, F.
Bacigal, T.
XIV MEDITERRANEAN CONFERENCE ON MEDICAL AND BIOLOGICAL ENGINEERING AND COMPUTING 2016, 2016, 57 : 1125 - 1130

← 1 2 3 4 5 →